Health Products

Bravelle (2015-10-23)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
Lot H15940BBravelle
Recalling Firm
Ferring Inc.
200 Yorkland Blvd., Suite 800,
North York
M2J 5C1
Ontario
CANADA
Marketing Authorization Holder
Ferring Inc.
200 Yorkland Blvd., Suite 800,
North York
M2J 5C1
Ontario
CANADA
Poudre lyophilisée stérile pour injectionDIN 02268140Urofollitropin 75 IU

Introduction

Affected Products

Bravelle

Reason

Out of specification result for potency during shelf life testing.

Depth of distribution

Clinics, hospitals and/or wholesalers in all provinces/territories
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime